Skip to content

Application of intranasal dexmedetomidine in pediatric surgery

Application of intranasal dexmedetomidine in pediatric surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041739
Enrollment
Unknown
Registered
2021-01-03
Start date
2021-01-04
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

4/5000 Pediatric hernia

Interventions

BDcau:dexmedetomidine and levobupivacaine sacral canal block
BDnas:Dexmedetomidine intranasal and levobupivacaine sacral canal block
B:Levobupivacaine sacral block

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients scheduled to undergo hernia surgery,aged 2-5 years old, ASA class I.

Exclusion criteria

Exclusion criteria: Patients with clotting dysfunction, patients with systemic infection or infection at puncture site, patients with known combination of neurofunctional disease or mental disorder, and patients with known local anesthetic allergy.

Design outcomes

Primary

MeasureTime frame
FLACC score;

Countries

China

Contacts

Public ContactDai Shuangbo

Fujian Provincial Hospital

dsbosl@126.com+86 13358215103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026